Jaguar Health Inc (JAGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -39,034 | -29,057 | -18,872 | -9,151 | -41,870 |
| Depreciation Amortization | 2,632 | 2,039 | 1,443 | 884 | 15,594 |
| Accounts receivable | 526 | 878 | 814 | 465 | 298 |
| Accounts payable and accrued liabilities | 328 | -423 | -875 | -1,660 | -855 |
| Other Working Capital | -3,010 | -1,571 | -1,393 | -153 | -11,099 |
| Other Operating Activity | 9,174 | 6,576 | 3,666 | 2,568 | 4,690 |
| Operating Cash Flow | $-29,384 | $-21,558 | $-15,217 | $-7,047 | $-33,242 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -16 | -16 | -16 | N/A | N/A |
| Purchase Sale Intangibles | -215 | N/A | N/A | N/A | N/A |
| Other Investing Activity | -215 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-231 | $-16 | $-16 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 31,910 | 28,909 | 25,158 | 12,490 | 33,336 |
| Other Financing Activity | -708 | -537 | -316 | -222 | 891 |
| Financing Cash Flow | $31,202 | $28,372 | $24,842 | $12,268 | $34,227 |
| Exchange Rate Effect | -54 | 2 | -29 | -19 | 15 |
| Beginning Cash Position | 6,469 | 6,469 | 6,469 | 6,469 | 5,469 |
| End Cash Position | 8,002 | 13,269 | 16,049 | 11,671 | 6,469 |
| Net Cash Flow | $1,533 | $6,800 | $9,580 | $5,202 | $1,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | -29,384 | -21,558 | -15,217 | -7,047 | -33,242 |
| Capital Expenditure | -16 | -16 | -16 | N/A | N/A |
| Free Cash Flow | -29,400 | -21,574 | -15,233 | -7,047 | -33,242 |